FDA Adverse Event Injury Summary report: N

APTIMA HPV SCREENING ASSAY

MDR report key: 22840306 · Received August 19, 2025

Report

Report Number
2024800-2025-00055
Event Type
Injury
Date Received
August 19, 2025
Date of Event
July 31, 2025
Report Date
August 19, 2025
Manufacturer
HOLOGIC, INC.
Product Code
OYB
UDI-DI
15420045500051
PMA / PMN Number
P100042
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

HOLOGIC THOROUGHLY REVIEWED THE PANTHER INSTRUMENT LOGS AND CUSTOMER WORKLISTS AND NOTED NO INDICATION OF AN UNDERLYING HARDWARE ISSUE. HOLOGIC DETERMINED THE MOST LIKELY CAUSE OF THE DISCREPANT RESULT WAS A LOW TARGET SAMPLE. HOLOGIC PERFORMED A RISK ASSESSMENT AND NOTED NO PRODUCT IMPACT. HOLOGIC HAS NOT BEEN INFORMED OF ANY ADVERSE PATIENT OUTCOMES RELATED TO THIS ISSUE.

Description of Event or Problem · 0

ON (B)(6) 2025, A CUSTOMER REPORTED TO HOLOGIC A DISCREPANT RESULT ON PANTHER INSTRUMENT (SERIAL NUMBER: (B)(6) USING THE APTIMA HPV (HUMAN PAPILLOMAVIRUS) ASSAY (MASTER LOT: 909954). THE CUSTOMER REPORTED THAT PER LAB IQA PROCEDURES, THEY SELECT RANDOM SAMPLES TO RETEST. ON (B)(6) 2025, SAMPLE (B)(6) INITIALLY RESULTED HPV NEGATIVE UNDER WORKLIST(B)(4). ON THE SAME DAY, THE SAME SAMPLE WAS RETESTED AS SAMPLE ID (B)(6) UNDER WORKLIST (B)(4) AND RESULTED HPV POSITIVE. ON (B)(6) 2025, THE CUSTOMER DECIDED TO RETEST THE SAMPLE (B)(6) FROM THE ORIGINAL THINPREP VIAL AND SAMPLE RESULTED POSITIVE UNDER WORKLIST (B)(4). THE CUSTOMER REPORTED THE FIRST VALID RESULT (NEGATIVE RESULT FROM (B)(6) 2025). HOLOGIC HAS NOT BEEN INFORMED OF ANY PATIENT TREATMENT OR ANY ADVERSE PATIENT OUTCOMES RELATED TO THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
251117 APTIMA HPV SCREENING ASSAY KIT, RNA DETECTION, HUMAN PAPILLOMAVIRUS OYB HOLOGIC, INC. 909954 15420045500051

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other